Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2101
https://www.valueinhealthjournal.com/article/S1098-3015(14)04031-5/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1566
First Page :
A604
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04031-5&doi=10.1016/j.jval.2014.08.2101